Direct Relief and the Pfizer Foundation Announce New Grantees in Fifth Year of Infectious Disease Program

NORTHAMPTON, MA / ACCESS Newswire / April 28, 2026 / Direct Relief and The Pfizer Foundation today announced the third cohort of the Innovation Awards in Community Health, supporting infectious ...

Pfizer (PFE) Among Best Medical Stocks Under $30 to Invest In?

Pfizer Inc. (NYSE: PFE) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, ...
Morningstar

U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancer Pivotal results from the Phase 3 portion with mFOLFOX6 of the ...
The Motley Fool

Where Will Pfizer Be in 5 Years?

Pfizer's stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live with the coronavirus, and Pfizer's stock has plunged as a result. Faced with patent ...
The Motley Fool

Should You Avoid Pfizer? Here's the Key Risk to Watch

Pfizer’s revenue reached $100 billion a few years ago, driven by its dominance in coronavirus treatments and prevention. In recent times, it’s faced a drop in that demand and losses of exclusivity ...
Seeking Alpha

U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Inc. today announced that the U.S. Food and Drug Administration has granted full approval to BRAFTOVI ® in combination with cetuximab and fluorouracil-based chemotherapy for the treatment of ...